Xperi Vs. Aligos Therapeutics Industry Stock Comparison

Buy

63

XPER
Xperi

Last Price:

$10.34

Seasonality Move:

16.38%

Buy

69

ALGS
Aligos Therapeutics

Last Price:

$43.44

Seasonality Move:

-17.17%

Buy

63

Xperi (XPER) is a Buy

Is Xperi a Buy, Sell or Hold?

The current Xperi [XPER] share price is $10.34. The Score for XPER is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
XPER is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

69

Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XPER Stock Price Chart

What is Xperi's stock price today?

The Xperi share price today is $10.34

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XPER is experiencing slight buying pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

The Aligos Therapeutics share price today is $43.42

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

XPER Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.25	Buy
Relative Strength Index (14 RSI):	58.63	Buy
Chaikin Money Flow:	10277	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(9.63 - 10.47)	Buy
Bollinger Bands (100):	(8.33 - 9.85)	Buy

ALGS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	5.14	Buy
Relative Strength Index (14 RSI):	74.33	Buy
Chaikin Money Flow:	210748	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(27.82 - 40.1)	Buy
Bollinger Bands (100):	(6.77 - 28.07)	Buy

XPER Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	10.26	Buy
20-day SMA:	10.2	Buy
50-day SMA:	9.5	Buy
200-day SMA:	9.1	Buy
8-day EMA:	10.28	Buy
20-day EMA:	10.1	Buy
50-day EMA:	9.65	Buy
200-day EMA:	9.35	Buy

ALGS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	40.78	Buy
20-day SMA:	36.11	Buy
50-day SMA:	23.97	Buy
200-day SMA:	16.97	Buy
8-day EMA:	40.32	Buy
20-day EMA:	35.95	Buy
50-day EMA:	27.43	Buy
200-day EMA:	19.22	Buy

Xperi Earnings Growth & XPER Earnings Dates

Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

Xperi Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):